Golf Superstore Uses Descartes Sellercloud™ to Unify Omnichannel Operations 
PCG Participates in MarTech Summit and Low Carbon Living Symposium and Launches Summer Promotions with PayMe 
Imagen Network Introduces Adaptive Feed Orchestration for More Natural Decentralized Interactions 
A-Sales Transitions to Performance-Based Lead Generation Model Mouser Now Direct Authorized Global Distributor of Raspberry Pi Products
DALLAS & FORT WORTH, Texas–(BUSINESS WIRE)–Mouser Electronics, Inc., the authorized global distributor with the newest…
LexFusion Deepens Bench of Legal Technology Talent to Focus on Corporate Legal Operations, Commercial Transactions, and Knowledge Management
Legal Industry Veteran, Christina Wojcik to Lead LexFusion’s Corporate Legal Operations, Commercial Transactions, and Innovation…
HamptonRock Launches Transaction Advisory and CFO Services Practice
Daniel Villarreal, Philip Fritsche, and Ryan Bailey join HamptonRock to lead the growth and development…
Veero® Brings Its Powerful Eyewear Fit-Optimization Technology to Brick-and-Mortar Retail and Optical Stores with New Veero EyeSize IRL
Easy-to-use eyewear retail solution captures customers’ precise facial measurements to fit frames and elevate the…
CARGO Therapeutics Announces Appointment of Michael Ports, PhD, as Chief Scientific Officer
– Scientific leader with multi-company cell therapy drug development experience spanning early discovery initiatives through late-stage…
CARGO Therapeutics Announces Appointment of Michael Ports, PhD, as Chief Scientific Officer
– Scientific leader with multi-company cell therapy drug development experience spanning early discovery initiatives through late-stage…
Sorrento Announces Phase 3 Trial Met Primary Endpoint and Key Secondary Endpoint in Mild or Moderate COVID-19 Adult Patients Treated with Ovydso (Olgotrelvir), an Oral Mpro Inhibitor as a Standalone Treatment for COVID-19
In the phase 3 trial, a randomized double blind and placebo-controlled pivotal study, 1,212 mild…
Sorrento Announces Phase 3 Trial Met Primary Endpoint and Key Secondary Endpoint in Mild or Moderate COVID-19 Adult Patients Treated with Ovydso (Olgotrelvir), an Oral Mpro Inhibitor as a Standalone Treatment for COVID-19
In the phase 3 trial, a randomized double blind and placebo-controlled pivotal study, 1,212 mild…
Scilex Holding Company Presented Oral and Poster Presentations on Elyxyb at the 2023 Annual Brain Week Conference Held in Las Vegas, NV
PALO ALTO, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex”…
Scilex Holding Company Presented Oral and Poster Presentations on Elyxyb at the 2023 Annual Brain Week Conference Held in Las Vegas, NV
PALO ALTO, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex”…
Scilex Holding Company Presented Oral and Poster Presentations on ZTlido (lidocaine topical system) at the 2023 Annual PAINWeek Conference Held in Las Vegas, NV
PALO ALTO, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex”…
Scilex Holding Company Presented Oral and Poster Presentations on ZTlido (lidocaine topical system) at the 2023 Annual PAINWeek Conference Held in Las Vegas, NV
PALO ALTO, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex”…
In Recognition of Suicide Prevention Month, NeuroStar Voices Portal Amplifies Stories of Real People Beating Depression
Portal provides resources to raise awareness around mental health and suicide prevention MALVERN, Pa., Sept….
In Recognition of Suicide Prevention Month, NeuroStar Voices Portal Amplifies Stories of Real People Beating Depression
Portal provides resources to raise awareness around mental health and suicide prevention MALVERN, Pa., Sept….
Entera Bio Announces Collaboration with OPKO Biologics to Develop Oral Peptide Tablet Formulations for Obesity and Intestinal Malabsorption Syndromes
JERUSALEM, Sept. 12, 2023 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX, “Entera”) and OPKO…
Entera Bio Announces Collaboration with OPKO Biologics to Develop Oral Peptide Tablet Formulations for Obesity and Intestinal Malabsorption Syndromes
JERUSALEM, Sept. 12, 2023 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX, “Entera”) and OPKO…
GSAC Engineering Acquires Key Intellectual Property and Assets from Duos Technologies Group
GelStat’s Subsidiary, GSAC Engineering, Launches Intelligent Correctional Facilities Automation Systems (iCAS) in the Industrial Security…
GSAC Engineering Acquires Key Intellectual Property and Assets from Duos Technologies Group
GelStat’s Subsidiary, GSAC Engineering, Launches Intelligent Correctional Facilities Automation Systems (iCAS) in the Industrial Security…
Bolt Biotherapeutics Announces Issuance of U.S. Patent Covering Dectin-2-Targeting Agonist Antibodies, Including BDC-3042
REDWOOD CITY, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) — Bolt Biotherapeutics, Inc. (Nasdaq: BOLT), a…
Bolt Biotherapeutics Announces Issuance of U.S. Patent Covering Dectin-2-Targeting Agonist Antibodies, Including BDC-3042
REDWOOD CITY, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) — Bolt Biotherapeutics, Inc. (Nasdaq: BOLT), a…